Emergency of Vaccines to destroy coronavirus disease | Infectious Diseases | Read Vaccines Market 2019-2027

Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. Significant progress has been made in expanding the coverage of vaccines globally, resulting in the prevention of more than two million deaths annually.

The growth of this market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines.

According to the Global Burden of Diseases and Institute for Health Metrics and Evaluation, the number of deaths caused by vaccine-preventable diseases such as tuberculosis decreased from 1.7 million in 2000 to 1.2 million in 2016. Moreover, although the incidence of Hepatitis is increasing year on year, the number of deaths caused by hepatitis B has decreased from 33.8 thousand in 2005 to 21.4 thousand in 2016. The decreasing incidence of death caused by vaccine-preventable infectious and other diseases is the evidence for the high adoption of vaccination.

Read complete research @ https://www.meticulousresearch.com/product/vaccines-market-5076/

Vaccines Market by Indication (Influenza, Rotavirus, DTP Vaccines), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccine, Live Attenuated Vaccine), Valence (Multivalent, Monovalent Vaccines) - Global Forecast to 2027

The global vaccines market is expected to grow at a CAGR of ~5.2% from 2019 to 2027 to reach $62.2 billion by 2027.

The high prevalence of infectious diseases, increasing government initiatives towards immunization, technological advancements in the vaccine industry, and a strong pipeline for vaccines are the key factors driving steady growth in the global vaccines market. Furthermore, increasing epidemic potentials, growing focus on therapeutic vaccines, and emerging markets offer significant revenue growth opportunities for the players operating in this market.

Request free Sample report @ https://www.meticulousresearch.com/request-sample-report/cp_id=5076

Scope of the Report:

Global Vaccines Market, by Indication
Pneumococcal Disease
Influenza
DTP
Human Papilloma Virus (HPV)
Meningococcal Disease
Poliomyelitis (Polio)
MMR
Rotavirus
Hepatitis
Other Indications

(Note: Other indications include varicella, herpes zoster vaccines, chlorella, and rabies vaccines.)

Global Vaccines Market, by Route of Administration

Intramuscular (IM)
Subcutaneous (SC)
Oral
Other Routes

(Note: Other routes include intradermal (ID), transcutaneous (TC), and nasal route)

Global Vaccines Market, by Type/Antigen

Subunit & Conjugate Vaccines
Inactivated vaccines
Live Attenuated Vaccines
Toxoid vaccines
Combination Vaccines

Global Vaccines Market, by Valence

Multivalent Vaccines
Monovalent vaccines

Global Vaccines Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Speak to our analyst
https://www.meticulousresearch.com/speak-to-analyst/cp_id=5076

Additional Insights-

In addition to global opportunity analysis and market forecasts, the Vaccines Market study provides detailed insights on regulatory analysis, product pipeline analysis, pricing analysis, and unmet need analysis. The study also showcases competitive benchmarking for top market players, by product and geography. The competitive landscape of this study also provides market share analysis, by market players and vaccines brand.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global vaccines market are Sanofi (France), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Daiichi Sankyo Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), and AstraZeneca (U.K.).

TOP 10 VACCINES MANUFACTURERS 2019 @ https://meticulousblog.org/top-10-companies-in-vaccines-market/

Key questions answered in the report-

What is Vaccines Market?
What are the market size forecasts and CAGR from the period 2019-2027?
Which are the largest and fastest growing vaccine types of the market?
What are the major drivers of the market?
What are the major restraints of the global vaccines market?
What are the major opportunities in the global market?
What are the major challenges in the global market?
Who are the major key players operating in the global vaccines market?
What are high growth countries/regions in the market?

Download Sample Report NOW !! https://www.meticulousresearch.com/download-sample-report/cp_id=5076

Contact us

Mr. Khushal Bombe
Meticulous Research
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

This release was published on openPR.